Home > Financial Ratios > THYROCARE TECHNOLOGIES

THYROCARE TECHNOLOGIES
Core EBITDA Growth

    Back to All Ratios
THYROCARE TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

THYROCARE TECHNOLOGIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 39.0013.12-50.5844.251.91

What is the latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES ?

The latest Core EBITDA Growth ratio of THYROCARE TECHNOLOGIES is 39.00 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202539.00
Mar202413.12
Mar2023-50.58
Mar202244.25
Mar20211.91

How is Core EBITDA Growth of THYROCARE TECHNOLOGIES Trending?

Years Core EBITDA Growth % Change
Mar2025 39
197.26
Mar2024 13.12
Positive
Mar2023 -50.58
Negative
Mar2022 44.25
2,216.75
Mar2021 1.91 -

Other Financial Ratios of THYROCARE TECHNOLOGIES


Compare Core EBITDA Growth ratio of peers of THYROCARE TECHNOLOGIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES ₹6,284.4 Cr -3.9% -5.9% 64.6% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹112,443.0 Cr 1.7% 12.4% 23.1% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹106,237.0 Cr 0.8% 14.1% 9.9% Stock Analytics
FORTIS HEALTHCARE ₹71,124.6 Cr 2.5% 10.6% 55.8% Stock Analytics
NARAYANA HRUDAYALAYA ₹37,468.5 Cr -1.9% 3.7% 32.2% Stock Analytics
GLOBAL HEALTH ₹30,667.6 Cr -2.1% 8.1% -5.9% Stock Analytics


THYROCARE TECHNOLOGIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THYROCARE TECHNOLOGIES

-3.9%

-5.9%

64.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses